Topic
FDA: news, timeline and key numbers
As of 31 October 2026, Oesnada has published 3 stories about FDA, 3 of them in the last 30 days. The most recent, "FDA Seeks to Withdraw Drug Approval, but the Process Is Not Simple", was published on 31 October 2026. The highest importance score among them is 95 out of 100.
- Stories, last 30 days
- 3
- Stories, last 365 days
- 3
- Highest importance
- 95/100
- Most recent story
- 31 October 2026
The story so far
On October 12, a KFF Health News investigation reported that Trump administration health officials had spent over a year working privately with technology companies in an unannounced Slack chat room. The companies included Microsoft, OpenAI, Anthropic, Apple and Google. The Centers for Medicare & Medicaid Services used the forum to give industry leaders direct access to top regulators and to shape federal policy on artificial intelligence in healthcare.
On October 28, Health Secretary Robert F. Kennedy Jr. issued a rule letting specialty compounding pharmacies make and sell six peptide drugs. The move overruled FDA scientists. It avoided the need to formally reverse a 2023 FDA decision that had removed the six peptides from the list of drugs compounding pharmacies can make, a step taken over safety concerns.
On October 31, the FDA proposed withdrawing approval of Tavneos, a drug for ANCA-associated vasculitis, a rare autoimmune disease. The process is not simple, and the case matters beyond one drug.
Written automatically from Oesnada story summaries of the last 90 days; no outside sources.
Timeline
- FDA Seeks to Withdraw Drug Approval, but the Process Is Not Simple
The case matters well beyond one drug.
Importance 90/100 - RFK Jr. Unilaterally Grants Access to Peptides, Overruling FDA
The move sidesteps the need to formally reverse a 2023 FDA decision that removed the six peptides from the list of drugs compounding pharmacies can make, a step taken over safety concerns.
Importance 95/100 - Medicare Agency Slack Lets Tech Giants Shape AI Medical Records Policy
According to an investigation by KFF Health News, which examined thousands of internal messages, meeting transcripts, and recordings, the Centers for Medicare & Medicaid Services (CMS) used the closed forum to grant industry leaders direct access to top regulators.
Importance 95/100
Related topics
Frequently asked questions
What is the latest FDA news?
The latest Oesnada story about FDA is "FDA Seeks to Withdraw Drug Approval, but the Process Is Not Simple", published on 31 October 2026.
How many stories has Oesnada published about FDA?
Oesnada has published 3 stories about FDA: 3 in the last 30 days and 3 in the last 365 days.
Which FDA story mattered most?
The story with the highest importance score is "RFK Jr. Unilaterally Grants Access to Peptides, Overruling FDA" (95 out of 100), published on 28 October 2026. Importance is an automated score from 0 to 100.
Methodology and sources
Oesnada lists every published story that names this subject. A subject gets a page once at least three stories mention it. Subjects are identified automatically from story text. Importance is an automated score from 0 to 100 assigned to each story; it is a model judgement, not a measurement. The summary above is written by a language model from Oesnada summaries only and regenerates when a new story arrives.
Cite this page
Oesnada, "FDA: news, timeline and key numbers", https://oesnada.com/topics/fda, accessed 31 October 2026.